WO2023148116 - THERAGNOSTIC FOLATE CONJUGATES
National phase entry:
Publication Number
WO/2023/148116
Publication Date
10.08.2023
International Application No.
PCT/EP2023/052117
International Filing Date
30.01.2023
Title **
[English]
THERAGNOSTIC FOLATE CONJUGATES
[French]
CONJUGUÉS DE FOLATE THÉRANOSTIQUES
Applicants **
MERCK PATENT GMBH
Frankfurter Strasse 250
64293 DARMSTADT, DE
Inventors
GROEHN, Viola
c/o Merck & Cie [Altdorf]
Weisshausmatte
6460 ALTDORF / URI, CH
RENZ, Marie-Luise
c/o Merck & Cie [Altdorf]
Weisshausmatte
6460 ALTDORF / URI, CH
MOSER, Rudolf
c/o Merck & Cie [Altdorf]
Weisshausmatte
6460 ALTDORF / URI, CH
SCHIBLI, Roger
c/o Paul Scherrer Institute
Forschungsstrasse 111
5232 VILLIGEN, CH
MUELLER, Cristina Magdalena
c/o Paul Scherrer Institute
Forschungsstrasse 111
5232 VILLIGEN, CH
DEBERLE, Luisa Maria
c/o Paul Scherrer Institute
Forschungsstrasse 111
5232 VILLIGEN, CH
BECKER, Anna Elisabeth
c/o Paul Scherrer Institute
Forschungsstrasse 111
5232 VILLIGEN, CH
BUSSLINGER, Sara Dorina
c/o Paul Scherrer Institute
Forschungsstrasse 111
5232 VILLIGEN, CH
Priority Data
22154652.6
01.02.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1686 | |
| EPO | Filing, Examination | 9878 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 6510 |
Total: 19239 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
-iodophenyl)pentanoate, and further provides uses of such conjugates and/or pharmaceutical compositions thereof in diagnostic imaging, radionuclide therapy or theragnostic applications.[French]
-iodophényl)pentanoate, et concerne en outre des utilisations de tels conjugués et/ou de compositions pharmaceutiques de ceux-ci dans une imagerie diagnostique, une thérapie par radionucléides ou des applications théranostiques.